ES2043062T3 - Procedimiento de preparacion de una composicion farmaceutica y/o dietetica. - Google Patents

Procedimiento de preparacion de una composicion farmaceutica y/o dietetica.

Info

Publication number
ES2043062T3
ES2043062T3 ES89402257T ES89402257T ES2043062T3 ES 2043062 T3 ES2043062 T3 ES 2043062T3 ES 89402257 T ES89402257 T ES 89402257T ES 89402257 T ES89402257 T ES 89402257T ES 2043062 T3 ES2043062 T3 ES 2043062T3
Authority
ES
Spain
Prior art keywords
pharmaceutical
procedure
preparation
combination
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89402257T
Other languages
English (en)
Spanish (es)
Inventor
Henri Laborit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Application granted granted Critical
Publication of ES2043062T3 publication Critical patent/ES2043062T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES89402257T 1988-08-12 1989-08-10 Procedimiento de preparacion de una composicion farmaceutica y/o dietetica. Expired - Lifetime ES2043062T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8810886A FR2635264B1 (fr) 1988-08-12 1988-08-12 Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine

Publications (1)

Publication Number Publication Date
ES2043062T3 true ES2043062T3 (es) 1993-12-16

Family

ID=9369324

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89402257T Expired - Lifetime ES2043062T3 (es) 1988-08-12 1989-08-10 Procedimiento de preparacion de una composicion farmaceutica y/o dietetica.

Country Status (10)

Country Link
EP (2) EP0354848B1 (enExample)
JP (1) JP2785989B2 (enExample)
AT (1) ATE82122T1 (enExample)
CA (1) CA1341260C (enExample)
DE (2) DE68903448T2 (enExample)
ES (1) ES2043062T3 (enExample)
FR (1) FR2635264B1 (enExample)
GR (2) GR900300149T1 (enExample)
PT (1) PT91430B (enExample)
WO (1) WO1990001316A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660557B1 (fr) * 1990-04-09 1994-05-27 Endobio Groupe Etu Rech Risqu Compositions pharmaceutiques et/ou dietetiques contenant de la carnitine, de la lysine et de la methionine avec ou sans acide pantothenique.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1306147B1 (it) 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306186B1 (it) 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
IT1317042B1 (it) * 2000-06-14 2003-05-26 Biosalts Srl Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono.
JP6766044B2 (ja) * 2015-07-01 2020-10-07 株式会社明治 継粉形成抑制剤
AU2018258250A1 (en) * 2017-04-25 2019-12-12 Almeda Labs Llc Amino acid formulations for pancreatic viability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4465M (enExample) * 1965-06-28 1966-09-26
FR2119882A1 (en) * 1970-12-31 1972-08-11 Prugnaud Robert Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
DE68903448T2 (de) 1993-03-18
GR900300149T1 (en) 1991-09-27
JPH04500073A (ja) 1992-01-09
CA1341260C (fr) 2001-06-19
FR2635264B1 (fr) 1992-02-28
JP2785989B2 (ja) 1998-08-13
EP0354848B1 (fr) 1992-11-11
PT91430A (pt) 1990-03-08
WO1990001316A1 (fr) 1990-02-22
ATE82122T1 (de) 1992-11-15
GR3006598T3 (enExample) 1993-06-30
DE354848T1 (de) 1992-05-21
EP0354848A1 (fr) 1990-02-14
FR2635264A1 (fr) 1990-02-16
EP0428608A1 (fr) 1991-05-29
DE68903448D1 (de) 1992-12-17
PT91430B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
NO306655B1 (no) Anvendelse av GLA, DGLA eller LA ved fremstilling av et medisinsk preparat
BR9205526A (pt) Misturas de oleos microbianos e usos dos mesmos
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
NO893239D0 (no) Farmasoeytisk preparat for behandling av diabetes mellitus.
BR8802852A (pt) Processo para a preparacao de compostos,processo para a preparacao de uma composicao,processo e composicoes para combater ou impedir uma infestacao das plantas
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
PT1216041E (pt) Dieta com elevado teor de lipidos
NO862409L (no) Preparat mot akner.
AU4603293A (en) Antiperspirant actives and compositions
ES2043062T3 (es) Procedimiento de preparacion de una composicion farmaceutica y/o dietetica.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
SE8902607D0 (sv) Oxaza heterocycles and pharmaceutical compositions containing same
NO170011C (no) Analogifremgangsmaate til fremstilling av propanolaminderivater
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
DE69208171D1 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
GB2012163A (en) Composition for treating diarrhoea
IL57513A0 (en) 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354848

Country of ref document: ES